2-Ethoxybenzimidamide hydrochloride

Catalog No.: 
ACWSGH543
CAS No.: 
18637-00-8
Molecular Formula: 
C9H13ClN2O
Molecular Weight: 
200.67
2-Ethoxybenzimidamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g96%$124.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Ethoxybenzimidamide hydrochloride
IUPAC Name2-ethoxybenzimidamide hydrochloride
MDL No.MFCD05663676
Molecular FormulaC9H13ClN2O
Molecular Weight200.67
SMILESN=C(N)C1=CC=CC=C1OCC.[H]Cl
InChI KeyNGMHLSBQVIXGNZ-UHFFFAOYSA-N
SynonymAC-4503 | AMY40552 | CS-0079901 | 2-Ethoxybenzimidamidehydrochloride | A813028 | Benzenecarboximidamide, 2-ethoxy-, monohydrochloride | J-509303 | SY020187 | DTXSID00486481 | 2-ETHOXY BENZAMIDINE HCL | EC 606-080-9 | C93436 | 2-Ethoxybenzimidamide hydroch
CAS No.18637-00-8
PubChem CID12301244

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACWSGH543 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHBML302 route compound structure diagram
    ACHBML3026609-57-0In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACWSGH543 route product structure diagram
    ACWSGH54318637-00-8In Stock
Inquiry

2. ACWSGH543 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHBML302 route compound structure diagram
    ACHBML3026609-57-0In Stock
  2. Then
  3. ACWSGH543 route product structure diagram
    ACWSGH54318637-00-8In Stock
Inquiry

3. ACWSGH543 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWSGH543 route product structure diagram
    ACWSGH54318637-00-8In Stock
Inquiry

Comments (0)